Agape ATP Corporation Common Stock (ATPC) Stock Price
ATPCStock
$1.57−97.47%52W
Market Cap$1.57M
P/E—
PEG Ratio—
Div yield—
Beta0.53
ATPC Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-51.97%
Price vs S&P 500 (4W)-30.12%
VGM Score26.89
Industry Peers — Health Services(21)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
ATPCAgape ATP Corporation Common Stock | B | F | F | — | -26.9% | -295.9% | -5.1% | $1.57 |
| LFSTLifeStance Health Group, Inc. Common Stock | D | A | B | 464.3x | 61.1% | 4.9% | 3.4% | $11.74 |
| PRVAPrivia Health Group, Inc. Common Stock | C | B | C | 125.5x | 24.1% | 1.9% | 3.8% | $22.52 |
| WGSGeneDx Holdings Corp. Class A Common Stock | F | B | D | — | 25.4% | -21.8% | -38.7% | $63.61 |
| PNTGThe Pennant Group, Inc. Common Stock | D | B | B | 49.4x | 37.9% | 5.7% | 9.5% | $41.87 |
| USPHUS Physical Therapy Inc | C | D | C | 32.3x | 11.3% | 9.4% | 6.8% | $85.71 |
| INNVInnovAge Holding Corp. Common Stock | D | C | C | — | 15.9% | 0.3% | -1.1% | $8.85 |
| OMDAOmada Health, Inc. Common Stock | D | B | D | — | 8.3% | -0.8% | 1.8% | $17.63 |
| PIIIP3 Health Partners Inc. Common Stock | A | C | D | — | 2.8% | -9.9% | 10.3% | $4.14 |
| SRTAStrata Critical Medical, Inc. Class A Common Stock | B | B | C | 9.7x | 18.8% | -8.0% | 14.3% | $4.54 |
| ALPSALPS Group Inc Ordinary Share | — | — | D | — | — | — | — | $0.34 |
About Agape ATP Corporation Common Stock
Agape ATP Corp develops and sells nutritional supplements and skincare products designed to support cellular health, detoxification, and anti-aging. The company operates through two segments: its core skin care and wellness business, which provides health products and advisory services and generates the majority of revenue, and a green energy division offering renewable energy solutions. The company targets health-conscious consumers through its diversified product portfolio and wellness advisory services.